Cited by 362Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Treatment and ManagementDiabetes Management and Research

The DOI matches its Crossref record; 51 of the 52 references it cites were found in a registry or an index.

Postprandial Glucose Regulation and Diabetic Complications

Ceriello, Antonio·2004·Archives of Internal Medicine

DOI 10.1001/archinte.164.19.2090

Open this paper in CoChat — free account

Abstract

Atherosclerotic disease accounts for much of the increased mortality and morbidity associated with type 2 diabetes. Epidemiological studies support the potential of improved glycemic control to reduce cardiovascular complications. An association between glycosylated hemoglobin (HbA(1c)) level and the risk for cardiovascular complications has frequently been reported. Most epidemiological data implicate postprandial hyperglycemia in the development of cardiovascular disease, whereas the link between fasting glycemia and diabetic complications is inconclusive. Moreover, in many studies, postprandial glycemia is a better predictor of cardiovascular risk than HbA(1c) level. Postprandial glucose may have a direct toxic effect on the vascular endothelium, mediated by oxidative stress that is independent of other cardiovascular risk factors such as hyperlipidemia. Postprandial hyperglycemia also may exert its effects through its substantial contribution to total glycemic exposure. The present review examines the hypothesis that controlling postprandial glucose level is an important strategy in the prevention of cardiovascular complications associated with diabetes.

Integrity signals

Registry

Crossref · 10.1001/archinte.164.19.2090

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Biochemistry and molecular cell biology of diabetic complications
Brownlee, M. (2001) · Nature · doi:10.1038/414813a · Cited by 9,107
Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study
Stratton, I. M. (2000) · BMJ · doi:10.1136/bmj.321.7258.405 · Cited by 9,059
Diabetes and Cardiovascular Disease: The Framingham Study
Kannel, W. B. (1979) · JAMA · doi:10.1001/jama.1979.03290450033020 · Cited by 2,936
Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988–1994
Harris, M. I., Flegal, K. M., Cowie, C. C., Eberhardt, M. S., Goldstein, D. E., Little, R. R., Wiedmeyer, H.-M., & Byrd-Holt, D. D. (1998) · Diabetes Care · doi:10.2337/diacare.21.4.518 · Cited by 2,703
Acarbose Treatment and the Risk of Cardiovascular Disease and Hypertension in Patients With Impaired Glucose Tolerance: The STOP-NIDDM Trial
Chiasson, J.-L., Josse, R. G., Gomis, R., Hanefeld, M., Karasik, A., Laakso, M., & for The STOP-NIDDM Trial Research Group (2003) · JAMA · doi:10.1001/jama.290.4.486 · Cited by 1,624
Contributions of Fasting and Postprandial Plasma Glucose Increments to the Overall Diurnal Hyperglycemia of Type 2 Diabetic Patients
Monnier, L., Lapinski, H., & Colette, C. (2003) · Diabetes Care · doi:10.2337/diacare.26.3.881 · Cited by 1,461
Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria
Borch‐Johnsen, K., Neil, A., Balkau, B., Larsen, S. H., Nissinen, A. E. T., Pekkanen, J., Keinanen-Kiukaanniemi, S. M., Hiltunen, L. A., Kivelä, S., Tuomilehto, J. O., et al. (1999) · The Lancet · Cited by 1,272
Defining the Relationship Between Plasma Glucose and HbA1c
Rohlfing, C. L., Wiedmeyer, H.-M., Little, R. R., England, J. D., Tennill, A., & Goldstein, D. E. (2002) · Diabetes Care · doi:10.2337/diacare.25.2.275 · Cited by 987
Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up
Hanefeld, M., Fischer, S., Julius, U., Schulze, J., Schwanebeck, U., Schmechel, H., Ziegelasch, H. J., & Lindner, J. (1996) · Diabetologia · doi:10.1007/s001250050617 · Cited by 873
Measurement of Plasma Glucose, Free Fatty Acid, Lactate, and Insulin for 24 h in Patients With NIDDM
Reaven, G. M., Hollenbeck, C., Jeng, C.-Y., Wu, M. S., & Chen, Y.-D. I. (1988) · Diabetes · doi:10.2337/diab.37.8.1020 · Cited by 753

Flagged first, then by citations

Show all 52 references

1 of the 52 references couldn’t be matched to a known paper.

Sorted by citations

Items 301–362 of 362

Physical Factors of Food Influencing the Postprandial Blood or Plasma Glucose Level: A Narrative Review
Bipat, R., Magali, I., Soekhoe, R., & Toelsie, J. R. (2023) · Medical Research Archives · doi:10.18103/mra.v11i4.3739 · Cited by 1
Advances in microbial exopolysaccharides as α-amylase inhibitors: Effects, structure–activity relationships, and anti-diabetic effects in vivo
Zhang, L., Li, Z., Kong, H., Ban, X., Gu, Z., Hong, Y., Cheng, L., & Li, C. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.136174 · Cited by 1
Evaluation of toxicity and anti-amylase activity of 7, 8 dihydroxy coumarin (Daphnetin), a novel α-amylase blocker in vitro and in vivo
Kar, S., Dutta, S., Saha, S., Sarkar, K., Chatterjee, S., Giri, N., & Sil, P. C. (2025) · Toxicology Reports · doi:10.1016/j.toxrep.2025.101991 · Cited by 1
The three pathways of advanced glycation end product synthesis: Hodge, Namiki, and Wolff — a clinically oriented mechanistic synthesis with network-based implications
Fernandez, E. C. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1856036 · Cited by 2
Type 2 Diabetes and Concomitant Illness
Dungan, K. M., Harris, E., & Braithwaite, S. S. (2008) · Humana Press eBooks · doi:10.1007/978-1-60327-043-4_14 · Cited by 1
Effect of Miglitol, an α-Glucosidase Inhibitor, on Postprandial Glucose and Lipid Metabolism in Patients with Type 2 Diabetes
Kaneko, Y., Kuboki, K., Hiroi, N., Watanabe, T., NISHIMURA, C., & Yoshino, G. (2011) · The Showa University Journal of Medical Sciences · doi:10.15369/sujms.23.217 · Cited by 1
[Biphasic insulin aspart for the management of diabetic patients with unsatisfactory metabolic control].
Ríos, M. G. D. L., Wolff, C., & Duarte, E. (2007) · PubMed · Cited by 1
Glycemic Variations after Ingestion of Different Carbohydrate-Containing Foods Assessed by Continuous Glucose Monitoring in Healthy and Diabetic Individuals in Daily Life
Aoki, Y., & Onzuka, M. (2015) · Diabetes Research - Open Journal · doi:10.17140/droj-1-107 · Cited by 1
Diabetes Control: Insights from Complexity Science
Holt, T. (2012) · Springer eBooks · doi:10.1007/978-1-4614-4998-0_20 · Cited by 1
Mixed model of dietary fat effect on postprandial glucose-insulin metabolism from carbohydrates in type 1 diabetes
Noguchi, C. C. Y., Kunikane, N., Hashimoto, S., & Furutani, E. (2015) · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · doi:10.1109/embc.2015.7320263 · Cited by 1
Value of Glycated Hemoglobin (HbA1c%) as an Indicator of Severity of Acute Coronary Syndrome in Non-Diabetic Adults
KASEM, M. S. E. S. S. M. S., & EL-BARBARY, M. D. W. A. H. Y. H. (2018) · The Medical Journal of Cairo University/The Medical Journal of Cairo University · doi:10.21608/mjcu.2018.55142 · Cited by 1
Tratamiento con insulina aspártica bifásica en pacientes con diabetes en mal control metabólico: Experiencia clínica programada
Ríos, M. G. D. L., Wolff, C., & Duarte, E. (2007) · Revista médica de Chile · doi:10.4067/s0034-98872007001000004 · Cited by 1
“Variación en la HbA1c a las 12 semanas de tratamiento HbA1c Inicial Final Variación [Min; Max] [7,1; 14,3] [5,4; 12,6] [-7,7; 3,2] Promedio ± DE 10,1±1,7 8,4±1,4 1,7±1,8 Mediana* 10,0 8,3 1,3 * p <0,0001.”
Influential
Dyslipidemia in the Metabolic Syndrome
Hanefeld, M., & Schäper, F. (2005) · Elsevier eBooks · doi:10.1016/b978-84-8174-892-5.50021-8 · Cited by 1
Blood glucose self-monitoring among patients with diabetes mellitus type 2 in family medicine practice
Herenda, S., & Tahirović, H. F. (2009) · Medicinski pregled · doi:10.2298/mpns0908342h · Cited by 1
Cross-Over Study Comparing Postprandial Glycemic Increase After Addition of a Fixed-Dose Mitiglinide/Voglibose Combination or a Dipeptidyl Peptidase-4 Inhibitor to Basal Insulin Therapy in Patients with Type 2 Diabetes Mellitus
Ihana‐Sugiyama, N., Yamamoto‐Honda, R., Sugiyama, T., Tsujimoto, T., Kakei, M., & Noda, M. (2017) · Medical science monitor basic research/Medical science monitor. Basic research · doi:10.12659/msmbr.902218 · Cited by 1
To: Strey CH, Young J, Collier M, Florkowski CM, Shand BI, Scott RS (2004) The postprandial state does not impair endothelial function in women with Type 2 diabetes irrespective of glycaemic control. Diabetologia 47:1838–1846
The International Prandial Glucose Regulation Study Group, Ceriello, A., Hanefeld, M., Leiter, L. A., Monnier, L., Owens, D. R., Tajima, N., & Tuomilehto, J. (2005) · Diabetologia · doi:10.1007/s00125-005-1781-8 · Cited by 1
“Prandial glucose regulation is of great relevance to clinical practice and is included in many guidelines all over the world [7].”
Self-citation
Rapid-acting insulin glulisine: a new tool for postprandial glucose control
DAILEY, G. E. (2006) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.1.4.469 · Cited by 1
[Physiopathology of post-prandial hyperglycemia].
Scheen, A. J., & Paquot, N. (2006) · PubMed · Cited by 1
Utilização da espectroscopia de fluorescência para mensuramento de moléculas autoflurescentes em indivíduos diabéticos
Gomes, C. Z. (2011) · doi:10.11606/d.85.2011.tde-17062011-112436
The Real-Time Measurements of Blood Nitric Oxide (NO) and Hydrogen Peroxide (H2O2) Levels under Acute Hyperglycemia
Minni, M., Chen, Q., Bartol, K. D., Perkins, K., & Rueter, B. (2011) · Digital Commons - PCOM (Philadelphia College of Osteopathic Medicine)
Postmeal Glucose Compared to Oral Glucose Tolerance in Non-Diabetic Patients with Acute Myocardial Infarction
Arola, O. T., Nevalainen, P. I., Kotila, M., Huhtala, H., & Alanko, J. (2014) · The Open Diabetes Journal · doi:10.2174/1876524601407010020
“Keywords: Abnormal glucose tolerance, acute myocardial infarction, impaired glucose tolerance, newly diagnosed diabetes, oral glucose tolerance test, postprandial glucose, stress-induced hyperglycemia.”
Background
When to monitor fingerstick blood glucose?
WHITAKER, M. D. (2005) · Postgraduate Medicine · doi:10.3810/pgm.2005.11.1690
WITHDRAWN: Effect of blood glucose fluctuation on the function of rat pancreatic islets in vivo
Yanjun, W., Yue, X., & Li, S. (2011) · Regulatory Peptides · doi:10.1016/j.regpep.2011.09.002
Biphasic (Premix) Insulin Analogs in Type 2 Diabetes Mellitus
Mansour, A. A. (2008) · Recent Patents on Endocrine Metabolic & Immune Drug Discovery · doi:10.2174/187221408784534231
“They offer the advantage of being a more physiological treatment regimen, able to address prandial, as well as fasting, insulin requirements with one single injection, unlike basal insulins, which primarily address fasting glucose [26-30].”
Background
Predictive factors for successful treatment of diabetes type 2 at the special hospital 'Merkur' in Vrnjci Spa
Marijana, B.-P. (2013) · Medicinski casopis · doi:10.5937/mckg47-3470
An evaluation of postprandial glucose excursions in type 2 diabetic mellitus subjects on Monotard® HM (ge) versus Humulin N® or Humulin L® insulin, each in combination with metformin
Singh, N., Rambiritch, V., & Mayet, L. (2007) · South African Family Practice · doi:10.1080/20786204.2007.10873549
New developments to optimize postprandial glucose control with insulin in patients with diabetes
de Galan, B. E. (2012) · Diabetes Management · doi:10.2217/dmt.12.20
Insulinothérapie : insuline ou analogues ? Injection ou perfusion ? Boucle ouverte ou boucle fermée ?
Hilaire, D. D. L. H. S., Moreau, F., Sigrist, S., Pinget, M., & Jeandidier, N. (2010) · Médecine Nucléaire · doi:10.1016/j.mednuc.2010.07.002
Insulin glulisine: preclinical hallmarks and clinical efficacy
Schliess, F., & Heise, T. (2009) · Therapy · doi:10.2217/14750708.6.2.209
Glycemic Response to Common Serving Size of Selected Carbohydrate Rich Foods
Senray, K., & Singhania, P. R. (2015) · Journal of Research in Obesity · doi:10.5171/2015.614065
“Many complex biochemical and molecular events have been implicated in hyperglycemia-induced tissue damage (Ceriello et al 2004, Brownlee 2001, Lebovitz 2001).”
Background
Encuesta sobre el uso de premezclas de análogos de insulinas en pacientes con diabetes en México
Lavalle-Gonzalez, F. J., García, P. S., Limones, R. C., Escalante, C., Rosas, J. C., Alcalá, H. G., Blumenfeld, O. S., Mendoza, R. R., Luis Felipe Sánchez, A., Real, R., et al. (2012) · Medicina Interna de México
Fast-to-fed shift in glucose homeostasis: clues to an earlier detection of human prediabetic states
Patarrão, R. S. (2010) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Short-term aerobic exercise training in type 2 diabetes
Kearney, M. L. (2015) · MOspace Institutional Repository (University of Missouri) · doi:10.32469/10355/50150
Vinegars Effects on Hemoglobin A1c and Postprandial Glycemia in Individuals at Risk for Diabetes
Quagliano, S. (2013) · Arizona State University Library Digital Repository (Arizona State University)
Lifestyle and cardio-metabolic health
Cassidy, S. (2016)
Is HbA1c still the Gold Standard for Glycemic Control?
Borz, V. (2017) · Journal of Diabetic Complications & Medicine · doi:10.4172/2475-3211.1000e103
“In recent years, three large trials (ACCORD - ADVANCE -VADT) confirmed even the negative effects of tight glycemic control on cardiovascular risk in type 2 diabetes [2,3].”
Background
Exploring the Effectiveness and the Feasibility of a Social Cognitive Theory-Based Physical Activity Intervention in Type 2 Diabetes Patients in Yogyakarta City Indonesia
Arovah, N. I. (1905) · Queensland University of Technology · doi:10.5204/thesis.eprints.118193
Effects of High Intensity Interval Exercise versus Moderate Intensity Continuous Exercise on Blood Glucose Profiles of Individuals with Type 2 Diabetes
Terada, T. (2014) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r30m4k
A Prospective, Randomized, Open Label, Single-Centre Study for Assessment of Safety and Effectiveness of Recombinant Human Insulin 30/70 + Insulin Glulisine compared to Recombinant Human Insulin NPH + Regular in the Management of Type 2 Diabetes Mellitus Patients in the Philippines.
MERCADO-ASIS, L. B., Tanchee-Ngo, M. J., Mendoza, E., Mane, A., Vasam, A., Shah, A., & Jain, R. (2019) · Journal of Medicine University of Santo Tomas · doi:10.35460/2546-1621.2019-0010
Désordres glycémiques
(2014) · Elsevier eBooks · doi:10.1016/b978-2-294-73954-5.00004-4
Does Interrupting Prolonged Sitting With 10- or 20-Min Standing Attenuate Postprandial Glycemia and Blood Pressure in Middle-Aged and Older Adults With Type 2 Diabetes?
Freire, Y. A., Silva, C. A., Macêdo, G. A. D., Browne, R. A. V., de Oliveira, B. M., Martins, G. F. C., Farias-Junior, L. F., Brito, L. C., & Costa, E. C. (2021) · Journal of Aging and Physical Activity · doi:10.1123/japa.2020-0418
Repeated Glucose Spikes and Insulin Resistance Synergistically Increase Endothelial Function Vulnerability to High Glucose Levels through Redox Imbalance, and Bardoxolone Methyl (CDDO-Me) Ameliorates Endothelial DysfunctionPreprint
Ogiso, K., Shayo, S. C., Kawade, S., Hashiguchi, H., Deguchi, T., & Nishio, Y. (2021) · Research Square · doi:10.21203/rs.3.rs-731463/v1
Expectation for sweet taste changes peripheral glucose metabolism via basolateral amygdalaPreprint
Yamamoto, I., Yonekura, T., Ishimoto, T., Xu, S., Iijima, N., Kimura, K., Diano, S., & Toda, C. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.02.03.479066
“Postprandial hyperglycemia and chronic hyperglycemia are risk factors for diabetic complications (14, 15).”
Background
Désordres glycémiques
(2019) · Elsevier eBooks · doi:10.1016/b978-2-294-75889-8.00004-x · Cited by 1
Comparison between a multiple daily insulin injection regimen (basal once-daily glargine plus mealtime lispro) and continuous subcutaneous insulin infusion (lispro) using continuous glucose monitoring in metabolically optimized type 1 diabetes patients: A randomized open-labelled parallel study
Ruiz-de-Adana, M. S., Dominguez-Lopez, M.-E., González-Molero, I., Machado, A., Martin, V., Cardona, I., de la Higuera, M., Tapia, M. J., Soriguer, F., Ortiz, M. T. A., et al. (2016) · Medicina Clínica (English Edition) · doi:10.1016/j.medcle.2015.09.006
Diabetic Gastroparesis
Rayner, C. K., Jones, K. L., & Horowitz, M. (2011) · Humana Press eBooks · doi:10.1007/978-1-60761-552-1_16
Yarı-biyonik İnsan: Yapay Kalp ve Yapay Pankreas Taşıyan Hastada Beslenme Tedavisi ve İzlemi
Şahiner, E., Yilmaz, M. T., & Kızıl, M. (2023) · Journal of Nutrition and Dietetics · doi:10.33076/2023.bdd.1778
“Önde gelen ölüm nedenlerinden biri olan diyabetin tüm ölümler arasında yedinci sırada yer aldığı (5) ve 2019 yılında doğrudan diyabete bağlı 1.”
Add-on effect of proprietary Ayurvedic medicine Diabrishta-21 in managing glucose variability measured through continuous glucose monitoring device: A case report
Jain, A. K., Banerjee, D., Dubey, S. K., & Katiyar, C. K. (2023) · Journal of Ayurveda Case Reports · doi:10.4103/jacr.jacr_158_22
Advanced hybrid closed loop (artificial pancreas) and carbohydrate count in type 1 diabetes
Pollakova, D., Pantano, A. L., Folco, U. D., Nardone, M. R., & Tubili, C. (2024) · Mediterranean Journal of Nutrition and Metabolism · doi:10.3233/mnm-230125 · Cited by 1
“However there are some limitations and gaps in knowledge when implies to T1D, as most of these studies concern Type 2 Diabetes (T2D), and based on oral glucose challenge [4, 5, 21] or mixed meal models [22, 23] and not based on continuous glucose data as measured by CGM systems.”
Integrating Nutrition Therapy, Blood Glucose Monitoring, and Continuous Glucose Monitoring
Lyons, L., Powers, M. A., & Austin, M. M. (2017) · American Diabetes Association eBooks · doi:10.2337/9781580406482.ch22
Association between diabetes phenotypes with hypertension and cardiovascular diseases, using single-sample confirmatory testing: a national study
Molavizadeh, D., Asgari, S., Assarian, B. A., Azizi, F., & Hadaegh, F. (2025) · Acta Diabetologica · doi:10.1007/s00592-025-02484-5
“Notably, a great body of literature has shown an independent association between 2 h-PG and CVD events [ 37, 38 ].”
Correlation of Glycemic Status with Angiographic Severity of Coronary Artery Disease in Acute Coronary Syndrome
Prakash, V. R., Shariff, M. O., & Prakash, V. S. (2025) · Journal of the Association of Physicians of India · doi:10.59556/japi.73.1034
ACUTE EFFECTS OF VARIOUS EXERCISE MODALITIES ON GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES: A SYSTEMATIC REVIEW
Lazić, A., Jevtović−Stoimenov, T., & Trajković, N. (2025) · AFMN Biomedicine · doi:10.5937/afmnai42-55083
Postprandial Glycemia and Insulinemia Responses to a Standard and Modified Muffin in Healthy Adults and Adults with Type 2 Diabetes
Stoner, J. T., Buga, A., Crabtree, C. D., Robinson, B. T., Decker, D. D., Sapper, T. N., Kackley, M. L., Simons, C. T., Lee, K. C. L., & Volek, J. S. (2025) · Foods · doi:10.3390/foods14244318
“If sustained over time, the repeated consumption of sugar-containing food products, specifically desserts, can have untoward effects on the area under the curve for glycemia, insulinemia, and HbA1c—all comprising the cluster of etiologies underlying the early onset of metabolic syndrome and T2D [3].”
6-O-acetyldaidzen and frangulin B from Halodule uninervis as novel α-amylase inhibitors: A molecular dynamics perspective
Samala, T. R., Patil, K. S., John, E. T., Eerapagula, R., Mahato, A. K., & Sen, P. (2025) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2025.108848
The glycation pathway in type 2 diabetes and cardiovascular disease
Engelen, L. (2012) · doi:10.26481/dis.20121012le
Impact de la modulation de la digestibilité de l’amidon sur la variabilité et le contrôle glycémiques dans la prise en charge du diabète de type 2
Breyton, A.-E. (2020) · theses.fr (ABES) · doi:10.70675/eb520b42z27d5z41e1z9344z8d10b6ae7238
Pacemaker Lead Endocarditis Secondary to Staphylococcus aureus Infection From a Flash Glucose Monitor Insertion Site in a Patient With Type 1 Diabetes: A Case Report
Linn, K., Al-Hayek, H., Parsian, Z., & Dalpathadu, S. (2026) · Cureus · doi:10.7759/cureus.108483
“Poor glycemic control further increases susceptibility to infection [2,3].”
Non-Fasting Glucose Measures and Their Clinical Significance in Diabetes Diagnosis and Cardiovascular and Cancer Risk Prediction: A Narrative Review
Wang, Y., Song, D., Wu, T., & Othman, E. M. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27114734
“…have distinct advantages and limitations in terms of sensitivity, reproducibility, and clinical practicality, while the emerging non-fasting glucose measure PPG 4–7.9h may provide complementary insights into postprandial dysregulation and cardiometabolic risk [33,43,52,54,55,71–75] (Table 1).”
Methylglyoxal as a Convergent Mediator of Diabetic Complications: Generation, Protein Targets, Tissue Distribution, and Therapeutic Reduction—A Clinically Oriented Mechanistic Synthesis
Fernandez, E. C. (2026) · Biomolecules · doi:10.3390/biom16081104
Hericium erinaceus β‐Glucan Improves Post‐Prandial Glycemic Homeostasis in Association With Changes in Akkermansia muciniphila , Serum Metabolites, and Gut Hormones
Wang, Z., Shu, Y., Gong, P., & Yao, W. (2026) · Journal of Food Science · doi:10.1111/1750-3841.71341
Postprandial Blood Glucose Lowering Effect of Urtica cannabina L. and Its Chemical Profiling via UPLC–Triple‐TOF MS/MS
Li, Z., Yang, N., Xu, M., Wang, L., Liu, L., Zhao, X., & Yue, H. (2026) · Journal of Food Science · doi:10.1111/1750-3841.71417

Authors: Ceriello, A.
Affiliations: University of Udine (IT)
Corresponding author: Ceriello, Antonio
ORCID: Ceriello, Antonio
Venue: Archives of Internal Medicine
Publisher: American Medical Association (AMA)
Published: 2004-10-25
Volume: 164
Issue: 19
Pages: 2090
ISSN: 0003-9926 (ISSN-L)
DOI: 10.1001/archinte.164.19.2090
OpenAlex: W2037632798
Cited by: 362
References: 52
Citations by year: 2026: 7 · 2025: 16 · 2024: 8 · 2023: 10 · 2022: 13 · 2021: 15 · 2020: 12 · 2019: 19 · 2018: 15 · 2017: 12 · 2016: 22 · 2015: 15 · 2014: 11 · 2013: 19 · 2012: 23
FWCI: 12.81
Type: journal article
Language: en
Open access: closed
Locations: Archives of Internal Medicine (publishedVersion)
PubMed (publishedVersion)
Institutional Research Information System (University of Udine) (submittedVersion)
STM:n Hallinnonalan avoin julkaisuarkisto (Julkari) (submittedVersion)
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Keywords: postprandial blood glucose, postprandial hyperglycemia, type 2 diabetes, cardiovascular complications, atherosclerosis, glycemic control, HbA1c, oxidative stress, endothelial cell cytotoxicity, glycemic exposure, cardiovascular risk prediction
MeSH terms: Blood Glucose, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Humans, Postprandial Period, Diabetes Complications

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Postprandial Glucose Regulation and Diabetic Complications

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks